Target intelligence / Profile preview

Mycobacterium avium complex 30S ribosomal subunit (MAC 30S ribosome)

Target
MAC 30S ribosome
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The Mycobacterium avium complex (MAC) 30S ribosomal subunit is a critical ribonucleoprotein complex essential for bacterial protein synthesis, comprising the 16S ribosomal RNA (rRNA) and various ribosomal proteins (StatPearls, 2023). It functions as the primary site for the initiation of translation and the decoding of genetic information from messenger RNA (mRNA). MAC, which includes species such as M. avium and M. intracellulare, is a major cause of chronic lung disease and disseminated infections, particularly in patients with underlying pulmonary conditions or compromised immune systems (NIH, 2022). This subunit is the specific target for aminoglycoside antibiotics like amikacin, which bind to the A-site of the 16S rRNA to disrupt protein production and induce bacterial cell death (FDA, 2018). Clinical management of MAC is often complicated by the development of resistance, frequently linked to mutations in the rrs gene that encodes the 16S rRNA component of the 30S subunit (Journal of Clinical Microbiology, 2017). Consequently, the 30S subunit remains a focal point for both diagnostic resistance testing and the development of novel antimicrobial agents.

Other names
30S ribosomal subunit of Mycobacterium avium complexMAC 30S ribosomeMycobacterium avium complex small ribosomal subunit16S ribosomal RNA-protein complex
02

Mechanism of action

Inhibition of protein synthesis by binding to the A-site of the 16S ribosomal RNA within the 30S subunit, leading to mRNA misreading and inhibition of translocation (Nature, 2014).

03

Biological functions

Protein synthesisTranslation initiationmRNA decodingBacterial growth
04

Disease associations

Mycobacterium avium complex infectionNontuberculous mycobacterial lung diseaseDisseminated Mycobacterium avium complex infection
05

Safety considerations

OtotoxicityNephrotoxicityVestibulotoxicityDevelopment of antimicrobial resistance (rrs mutations)
06

Interacting drugs

Amikacin

6 more in the full profile.

07

Biomarkers

16S rRNA (rrs) gene mutationsSputum culture conversionAmikacin minimum inhibitory concentration (MIC)

Beyond the preview

Go deeper on Mycobacterium avium complex 30S ribosomal subunit (MAC 30S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium avium complex 30S ribosomal subunit (MAC 30S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call